Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CellTree is a South Korean biotechnology company specializing in the development of exosome-based therapeutics and regenerative medicine solutions. The company focuses on isolating and engineering high-purity exosomes derived from stem cells to treat inflammatory conditions and promote tissue regeneration. Beyond its therapeutic pipeline, CellTree leverages its platform technology to develop high-end cosmeceuticals and aesthetic treatments targeting skin rejuvenation and hair loss. By utilizing the natural signaling capabilities of exosomes, the company aims to provide next-generation cell-free therapies that offer improved safety and efficacy over traditional stem cell treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CellTree.